PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 7, 2017
Insider Transaction Report
Form 4
Tenbarge Bryce
Vice President, Commercial
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2017-03-01+66,000→ 66,000 totalExercise: $11.32Exp: 2027-03-01→ Common Stock (66,000 underlying)
Footnotes (1)
- [F1]3yr 33% On Vest beginning on 01-Mar-2017